reviewThe Lancet OncologyApr 29, 2008Closed access

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

The Netherlands Cancer Institute · Erasmus University Rotterdam · +2 more institutions

Indexed incrossref

Abstract

No abstract available for this paper.

Citation impact

1,110
total citations
FWCI
27.96
Percentile
100%
References
86
Citations per year

Authors

5

Topics & keywords

Keywords
  • Temozolomide
  • Medicine
  • Chemoradiotherapy
  • Radiation therapy
  • Asymptomatic
  • Chemotherapy
  • Dacarbazine
  • Glioma
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.